Miller Fischer syndrome after COVID-19 infection and vaccine: a systematic review.
Panayiota NeophytouArtemios ArtemiadisGeorgios M HadjigeorgiouPanagiotis ZisPublished in: Acta neurologica Belgica (2023)
MFS after COVID-19 infection/vaccination was found to have the typical epidemiological characteristics of classic MFS; being rare, occurring more often after infection than vaccination, affecting mainly middle-aged males usually within 3 weeks after the event and having an excellent prognosis after treatment with IVIG or even with no treatment at all. We found no evidence that MFS after COVID-19 infection was different from MFS after COVID-19 vaccination, although the former tended to occur earlier.